Absci Corp
NASDAQ:ABSI

Watchlist Manager
Absci Corp Logo
Absci Corp
NASDAQ:ABSI
Watchlist
Price: 3.99 USD -0.99% Market Closed
Market Cap: 453.1m USD
Have any thoughts about
Absci Corp?
Write Note

Intrinsic Value

ABSI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ABSI stock under the Base Case scenario is 1.51 USD. Compared to the current market price of 3.99 USD, Absci Corp is Overvalued by 62%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABSI Intrinsic Value
1.51 USD
Overvaluation 62%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Absci Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ABSI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ABSI?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Life Sciences Tools & Services Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Absci Corp

Provide an overview of the primary business activities
of Absci Corp.

What unique competitive advantages
does Absci Corp hold over its rivals?

What risks and challenges
does Absci Corp face in the near future?

Summarize the latest earnings call
of Absci Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Absci Corp.

Provide P/S
for Absci Corp.

Provide P/E
for Absci Corp.

Provide P/OCF
for Absci Corp.

Provide P/FCFE
for Absci Corp.

Provide P/B
for Absci Corp.

Provide EV/S
for Absci Corp.

Provide EV/GP
for Absci Corp.

Provide EV/EBITDA
for Absci Corp.

Provide EV/EBIT
for Absci Corp.

Provide EV/OCF
for Absci Corp.

Provide EV/FCFF
for Absci Corp.

Provide EV/IC
for Absci Corp.

Show me price targets
for Absci Corp made by professional analysts.

What are the Revenue projections
for Absci Corp?

How accurate were the past Revenue estimates
for Absci Corp?

What are the Net Income projections
for Absci Corp?

How accurate were the past Net Income estimates
for Absci Corp?

What are the EPS projections
for Absci Corp?

How accurate were the past EPS estimates
for Absci Corp?

What are the EBIT projections
for Absci Corp?

How accurate were the past EBIT estimates
for Absci Corp?

Compare the revenue forecasts
for Absci Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Absci Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Absci Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Absci Corp compared to its peers.

Compare the P/E ratios
of Absci Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Absci Corp with its peers.

Analyze the financial leverage
of Absci Corp compared to its main competitors.

Show all profitability ratios
for Absci Corp.

Provide ROE
for Absci Corp.

Provide ROA
for Absci Corp.

Provide ROIC
for Absci Corp.

Provide ROCE
for Absci Corp.

Provide Gross Margin
for Absci Corp.

Provide Operating Margin
for Absci Corp.

Provide Net Margin
for Absci Corp.

Provide FCF Margin
for Absci Corp.

Show all solvency ratios
for Absci Corp.

Provide D/E Ratio
for Absci Corp.

Provide D/A Ratio
for Absci Corp.

Provide Interest Coverage Ratio
for Absci Corp.

Provide Altman Z-Score Ratio
for Absci Corp.

Provide Quick Ratio
for Absci Corp.

Provide Current Ratio
for Absci Corp.

Provide Cash Ratio
for Absci Corp.

What is the historical Revenue growth
over the last 5 years for Absci Corp?

What is the historical Net Income growth
over the last 5 years for Absci Corp?

What is the current Free Cash Flow
of Absci Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Absci Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Absci Corp

Current Assets 165.2m
Cash & Short-Term Investments 145.2m
Receivables 44k
Other Current Assets 19.9m
Non-Current Assets 90.3m
PP&E 41m
Intangibles 46.6m
Other Non-Current Assets 2.8m
Current Liabilities 25.5m
Accounts Payable 1.7m
Accrued Liabilities 18.5m
Other Current Liabilities 5.3m
Non-Current Liabilities 8.6m
Long-Term Debt 3.1m
Other Non-Current Liabilities 5.4m
Efficiency

Earnings Waterfall
Absci Corp

Revenue
3.2m USD
Operating Expenses
-101.5m USD
Operating Income
-98.3m USD
Other Expenses
6m USD
Net Income
-92.3m USD

Free Cash Flow Analysis
Absci Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Absci announced a new partnership with Memorial Sloan Kettering Cancer Center, aiming to develop up to six therapeutic programs. Progress was also noted on internal assets ABS-101, ABS-201, and ABS-301. ABS-101 showed significantly extended half-life in studies. For Q2 2024, Absci reported $1.3 million in revenue with increased R&D expenses of $15.3 million. Despite higher expenses, cash reserves stood at $145.2 million, projected to fund operations into H1 2027. The company expects to secure three more partnerships by year-end, enhancing its diversified portfolio.

What is Earnings Call?
Fundamental Scores

ABSI Profitability Score
Profitability Due Diligence

Absci Corp's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
Declining ROE
Declining ROIC
15/100
Profitability
Score

Absci Corp's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

ABSI Solvency Score
Solvency Due Diligence

Absci Corp's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
77/100
Solvency
Score

Absci Corp's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABSI Price Targets Summary
Absci Corp

Wall Street analysts forecast ABSI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABSI is 8.45 USD with a low forecast of 6.06 USD and a high forecast of 13.65 USD.

Lowest
Price Target
6.06 USD
52% Upside
Average
Price Target
8.45 USD
112% Upside
Highest
Price Target
13.65 USD
242% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ABSI?

Click here to dive deeper.

Dividends

Absci Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for ABSI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Absci Corp Logo
Absci Corp

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

452.6m USD

Dividend Yield

0%

Description

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. The company is headquartered in Vancouver Washington, Washington and currently employs 216 full-time employees. The company went IPO on 2021-07-22. The firm has developed an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The company uses synthetic biology technologies and deep learning artificial intelligence (AI) to predict, identify, design, construct, screen, select and scale production of biologic drug candidates, and learn from the data it generates. The firm has drug candidates in approximately nine active programs, eight of the active programs are focused on developing production cell lines for drug candidates that the Company's partners are developing. The company has one discovery program, focused on lead optimization with Astellas. The Company’s active programs include Bispecific monoclonal antibodies (mAb), Bispecific T-cell engager, Cytokine, Fab, Multivalent Fc-fusion, Plasma protein and mAb.

Contact

WASHINGTON
Vancouver Washington
18105 Se Mill Plain Blvd, Suite 350
+13609491041.0
www.absci.com

IPO

2021-07-22

Employees

216

Officers

Founder, CEO, President & Director
Mr. Sean McClain
Chief Business Officer & CFO
Dr. Zachariah Jonasson Ph.D.
Chief Innovation Officer & Member of Scientific Advisory Board
Dr. Andreas Busch Ph.D.
Senior VP & Chief Accounting Officer
Mr. Todd Bedrick CPA
VP of Finance & Head of Investor Relations
Mr. Alexander Khan CPA
Chief Legal Officer
Ms. Shelby Walker J.D.
Show More
Chief People Officer
Ms. Karin Wierinck
Senior Vice President of Synthetic Biology R&D
Jens Plassmeier Ph.D.
Chief of Staff
Mr. Wen Sha
Show Less

See Also

Discover More
What is the Intrinsic Value of one ABSI stock?

The intrinsic value of one ABSI stock under the Base Case scenario is 1.51 USD.

Is ABSI stock undervalued or overvalued?

Compared to the current market price of 3.99 USD, Absci Corp is Overvalued by 62%.

Back to Top